Duquesne Family Office’s Q4 2025 13F filing disclosed a $4.49 trillion portfolio spanning 62 holdings. Duquesne initiated 27 new positions and exited 16 others, indicating a substantial portfolio re-evaluation. The top five holdings concentrated significant capital: NTRA comprised 12.8% of the portfolio, followed by XLF at 6.7%, INSM at 5.7%, RSP at 5.0%, and TEVA at 4.1%.

Druckenmiller staked over $300 billion on financials and nearly $250 billion on Brazil during Q4 2025. His largest new position, $300.99 billion in the Select Sector SPDR Financial ETF (XLF), suggests a strong belief in a steepening yield curve or a re-accelerating economy driving loan demand. He poured $134.32 billion and an additional $112.86 billion into the iShares Brazil ETF (EWZ), a collective $247.18 billion wager. This significant Brazil investment signals conviction in a weakening dollar and a commodity price rebound boosting emerging market assets. A $224.88 billion commitment to the Invesco S&P 500 Equal Weight ETF (RSP) implies he anticipates a broader market rally extending beyond dominant mega-cap technology companies.

A strong cyclical re-acceleration connects all Druckenmiller’s new Q4 2025 purchases. His $73.12 billion investment in Alcoa Corp. (AA) and $71.12 billion in Entegris Inc. (ENTG) reinforce this view. Alcoa, a materials producer, and Entegris, supplying materials to the semiconductor industry, directly benefit from an expanding industrial economy. Druckenmiller identifies an economy poised for renewed growth and demand, positioning his portfolio for an upturn 18 months in the future. He bets on global liquidity improving after a period of restrictive Federal Reserve policy.

Druckenmiller significantly expanded several existing positions during Q4 2025, betting big on a select group of companies. He increased his stake in NTRA by a staggering 2411%, pushing its value to $575.33 billion and establishing it as his largest holding. This aggressive scaling into an already established position signals profound conviction, a hallmark of his concentrated approach. He also substantially upped his allocation to Google, adding 277% to reach $120.50 billion, and to Sea Limited, boosting that position by 244% for a total of $120.44 billion.

Amazon saw a 69% increase, raising its value to $170.33 billion, while Coupang grew by 46% to $159.77 billion. The pattern of these additions, heavily skewed toward growth-oriented technology and e-commerce names, suggests a specific macro outlook. Druckenmiller sees the world 18 months ahead, and his bias towards liquidity and Federal Reserve policy over pure earnings momentum likely drives these decisions. These Q4 movements reflect a belief these companies will benefit disproportionately from anticipated shifts in financial conditions.

Stanley Druckenmiller executed significant Q4 2025 portfolio reductions, mirroring his forward-looking, liquidity-driven macro strategy. He predicts market conditions 18 months ahead, believing Federal Reserve policy dictates outcomes more than earnings. Docusign Inc. saw a 40% reduction, signaling a changed view on enterprise software valuations or growth. Insmed Inc., a biotechnology firm, had its position cut by 39%, indicating diminished conviction in speculative growth assets. These moves point to an expectation of tighter liquidity or altered policy affecting specific sectors.

Druckenmiller’s rapid mental flexibility drives his willingness to reverse positions when facts change. Teva Pharmaceutical Industries Ltd. experienced a deep 65% reduction. Taiwan Semiconductor Manufacturing Co. saw a 29% trim, a considerable cut for a critical global technology supplier. Mercadolibre Inc., the Latin American e-commerce giant, faced a 19% reduction. Woodward Inc., an industrial components manufacturer, also saw its stake cut by 7%. Each divestment reveals Druckenmiller’s re-evaluation of specific sector prospects and broader market risk within his changing macro outlook.